CIK 0001176309 · Non-accelerated filer<br>Smaller reporting company
ORAMED PHARMACEUTICALS INC.
Sign in to watch- Ticker
- ORMP
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 980376008
- Phone
- 646-844-1164
- Business address
- 1185 AVENUE OF THE AMERICAS, 3RD FLOOR, NEW YORK, NY, 10036
- Former names
- Integrated Security Technologies, Inc., IGUANA VENTURES LTD
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $225,530
- in 2 filings, $226K under 10b5-1 plans
Net −$225,530. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2026-09-24 | Kidron Miriam Chief Scientific Officer | Returned to the company · Stock option (right to buy) | −47,000 | 0 | ||
| 2026-09-24 | Kidron Miriam Chief Scientific Officer | Returned to the company · Stock option (right to buy) | −100,000 | 0 | ||
| 2026-09-24 | Kidron Miriam Chief Scientific Officer | Returned to the company · Stock option (right to buy) | −72,000 | 0 | ||
| 2026-09-24 | Gabay Avraham Chief Financial Officer | Grant or award | +209,291 | 881,076 | ||
| 2026-07-02 | Hexter Joshua COO & CBO | Option exercise | +50,000 | $3.69 | $185K | 1,073,384 |
| 2026-07-02 | Hexter Joshua COO & CBO | Option exercise · Stock option (right to buy) | −50,000 | 50,000 | ||
| 2026-07-01 | Hexter Joshua COO & CBO | Sale | −137,000 | $4.46 | $611K | 1,023,384 |
| 2026-07-01 | Gabay Avraham Chief Financial Officer | Sale | −73,360 | $4.51 | $331K | 671,785 |
| 2026-03-30 | KIDRON NADAV President and CEO | Shares withheld for taxes | −44,818 | $3.31 | $148K | 3,422,243 |
| 2026-03-30 | Kidron Miriam Chief Scientific Officer | Shares withheld for taxes | −435,084 | $3.31 | $1.4M | 1,133,138 |
| 2026-03-17 | Kidron Miriam Chief Scientific Officer | Grant or award | +119,558 | 1,568,222 | ||
| 2026-03-17 | KIDRON NADAV President and CEO | Grant or award | +167,005 | 3,422,243 | ||
| 2026-03-17 | Hexter Joshua COO & CBO | Grant or award | +95,889 | 1,160,384 | ||
| 2026-03-17 | Gabay Avraham Chief Financial Officer | Grant or award | +95,889 | 745,145 | ||
| 2026-03-12 | KIDRON NADAV President and CEO | Gift | −100,000 | 3,255,238 | ||
| 2026-01-22 | KIDRON NADAV President and CEO | Option exercise | +109,000 | 3,355,238 | ||
| 2026-01-22 | KIDRON NADAV President and CEO | Option exercise · Performance Stock Units | −109,000 | 0 | ||
| 2026-01-22 | Kidron Miriam Chief Scientific Officer | Option exercise | +19,000 | 1,448,664 | ||
| 2026-01-22 | Kidron Miriam Chief Scientific Officer | Option exercise · Performance Stock Units | −19,000 | 0 | ||
| 2026-01-22 | Hexter Joshua COO & CBO | Option exercise | +19,000 | 1,064,495 |
Page 2 of 9 · 170 trades